当前位置: 首页 >> 检索结果
共有 4689 条符合本次的查询结果, 用时 3.8207129 秒

4601. A Rare Case of an Intestinal Ulcer.

作者: Qiang Ma.;Qin Li.;Yanling Wei.
来源: Gastroenterology. 2022年162卷1期e7-e8页

4602. A Rare Liver Tumor Nodule.

作者: Chao Qu.;Hang-Yan Wang.;Dian-Rong Xiu.
来源: Gastroenterology. 2022年162卷2期e1-e3页

4603. An Unusual Cause of Right Upper Abdominal Pain.

作者: Tetsuo Hasegawa.;Shinya Nagae.;Hiroaki Taguchi.
来源: Gastroenterology. 2022年162卷2期e7-e10页

4604. Peroral endoscopic myotomy and septotomy for Zenker diverticulum.

作者: Rami El Abiad.;Elizabeth Brindise.;Michael Bejjani.;Bachir Ghandour.;Mouen Khashab.
来源: Minerva Gastroenterol (Torino). 2023年69卷2期217-231页
Zenker diverticulum (ZD) is the most common hypopharyngeal diverticulum seen often in septuagenarian and octogenarian males. Oropharyngeal dysphagia is the most common presenting symptom. Treatment of ZD has been advancing with the introduction of a wide variety of accessory devices, primarily focusing on obliteration of the septum by complete transection of the cricopharyngeus muscle to recreate the common cavity and restore normal pharyngo-esophageal bolus outflow. This review aimed to provide an overview of the various surgical and endoscopic treatment options for ZD, while focusing specifically on Zenker peroral endoscopic myotomy.

4605. Endoscopic management of difficult common bile duct stones.

作者: Markus Dollhopf.;Henning Schmetkamp.
来源: Minerva Gastroenterol (Torino). 2022年68卷2期144-153页
Common bile duct stones are a very frequent problem in the western world and endoscopic stone clearance is the method of choice for treatment. Despite its common use, endoscopic clearance of common bile duct stones is not always trivial especially in cases involving large or multiple stones.

4607. The Varying Costs of Endoscopic Surveillance May Affect the Follow-Up Endpoint Identified by Cost-Benefit Analysis in Barrett's Esophagus Patients Around the World.

作者: Zhi-Han Wu.;Rong Luo.;Kai Deng.
来源: Gastroenterology. 2022年162卷1期351页

4608. The expression and clinical significance of IQGAP3 in gastric cancer.

作者: Yin Huang.;Xia Jiang.;Qing Wang.;Zhenyan Gao.;Yugang Wu.
来源: Minerva Gastroenterol (Torino). 2022年68卷2期235-238页

4609. LncRNA BANCR promotes proliferation of hepatocellular carcinoma Huh-7 cells by activating Wnt/β-catenin signaling pathway.

作者: Yushan Yu.;Lu Zhang.;Jun Xu.
来源: Minerva Gastroenterol (Torino). 2022年68卷3期341-343页

4610. The Colorectal Cancer Lipidome: Are There Any Differences in Lipid Species Between Right and Left Colorectal Cancers?

作者: Junya Arai.;Yoku Hayakawa.;Kazuhiko Koike.
来源: Gastroenterology. 2022年162卷2期658页

4611. Protocol for systematic review of telemedicine in inflammatory bowel disease.

作者: Abby Saunders.;Lee Hill.;Jelena Popov.;Mona Kalantar.;Yasamin Farbod.;Prachi Terwari.;Usha Chauhan.
来源: Minerva Gastroenterol (Torino). 2023年69卷2期318-319页

4612. Telemedicine: historical roots, basic concepts, and today's use.

作者: Giovanni C Actis.
来源: Minerva Gastroenterol (Torino). 2022年68卷1期1-3页

4613. Hyperlipasemia does not confer worse clinical outcomes in a retrospective cohort of novel coronavirus patients.

作者: Zaid Imam.;Inayat Gill.;Bana Antonios.;Leen Hasan.;Andrew Aneese.;Gaurav Kakked.;Alexandra Halalau.
来源: Minerva Gastroenterol (Torino). 2023年69卷2期312-314页

4614. A case of autoimmune pancreatitis during the second wave of COVID-19.

作者: Giovanni Valentini.;Dario Mazzucco.;Immacolata Andria.;Monica Surace.
来源: Minerva Gastroenterol (Torino). 2023年69卷3期433-435页

4615. Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients.

作者: Ylenia Ingrasciotta.;Mauro Grova.;Federica Crispino.;Valentina Isgrò.;Fabrizio Calapai.;Fabio S Macaluso.;Francesco Mattace-Raso.;Gianluca Trifirò.;Ambrogio Orlando.
来源: Minerva Gastroenterol (Torino). 2024年70卷1期98-108页
Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are chronic diseases associated with increased morbidity and reduced quality of life. Age may represent a risk factor for adverse events, due to the multimorbidity and polypharmacy, common in elderly patients. Elderly are often not included in clinical trials evaluating efficacy and safety of study drugs for the treatment of inflammatory bowel diseases. Several drugs, such as aminosalicylates, systemic corticosteroids, immunosuppressant drugs, biological drugs and Janus Kinase inhibitors, are available for the management of inflammatory bowel diseases. Therefore, with the increasing spectrum of therapeutic options it is important to analyze the evidence regarding the safety of the use of these agents in elderly patients. Selection of immunosuppressive therapy is a challenge in the management of elderly patients with inflammatory bowel diseases, for whom biologics with a lower risk of infection or cancer, such as vedolizumab and ustekinumab, may be preferred in elderly patients. Concomitant therapies and comorbidities must be thoroughly investigated before initiating any immunosuppressive or biological therapy in order to minimize the risk of drug-drug interactions. This review aimed to provide an overview of the safety of thiopurines, methotrexate and target therapies as well as their drug-drug interactions in patients with inflammatory bowel diseases.

4616. Epidemiology and clinical course of late onset inflammatory bowel disease.

作者: Anna Viola.;Gionata Fiorino.;Giuseppe Costantino.;Walter Fries.
来源: Minerva Gastroenterol (Torino). 2024年70卷1期52-58页
With the increasing age of the general population in developed countries, the management of several chronic diseases becomes more and more complex due to comorbidities. Some, especially inflammatory bowel diseases, formerly believed to belong to the young adult population, have now been recognized as being present at disease onset also in the ageing population, representing medical challenges different from those in the younger population. In the past few years, knowledge on this special older population has increased, changing initial beliefs concerning epidemiology and course of disease. In the present review, we addressed the most recent evidence concerning their current incidence compared with other age groups, their clinical course, potential risk factors for the development of late-onset IBDs, associated diseases, and cancer risk beyond therapy-related neoplasias.

4617. Comments on Study of Single Metal Stent and Multiple Plastic Stents Insertion for Benign Biliary Strictures Secondary to Chronic Pancreatitis.

作者: Yu Liu.;Xiao-Yi Yin.;Liang-Hao Hu.
来源: Gastroenterology. 2022年162卷1期346页

4618. COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.

作者: Irving Levine.;Arun Swaminath.;Isabel Roitman.;Keith Sultan.
来源: Gastroenterology. 2022年162卷1期349-350页

4619. Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease.

作者: Federica Bellone.;Alberto Sardella.;Marco Muscianisi.;Giorgio Basile.
来源: Minerva Gastroenterol (Torino). 2024年70卷1期79-88页
Inflammatory bowel diseases (IBDs) are characterized by a multifactorial clinical picture, in which age-related physical, functional and psychological symptoms may coexist. The accurate evaluation and identification of such symptomatology acquires considerable importance in the context of older adults, since those core factors typical of IBD may also expose older patients to an increased risk for age-related negative outcomes, such as frailty and disability. The purpose of the present review was to provide an updated overview on the evaluation and management of IBD in the elderly population, with regard to fatigue, sarcopenia, and frailty. The assessment of fatigue might contribute to the identification of early symptoms of IBD, such as pain and mood disorders, which should be treated timely to offer elderly patient a better quality of life. Similarly, an accurate evaluation of sarcopenia might represent a useful Prognostic Index to identify those patients at risk of developing physical frailty. Frailty in IBD should be evaluated not only in relation to the occurrence of negative outcomes, but also should be considered itself as an outcome itself in IBD. A recommendation for future research on this topic might be the implementation of randomized trials, which include older adults and evaluate fatigue, sarcopenia, and frailty. Similarly, the development of tailored intervention programs, based on both physical and psychological outcomes, with the purpose of improving patients' adaptation to the disease, and monitoring the evolution of symptoms and the response to therapies over time, should be encouraged.

4620. Role of endoscopic ultrasonography in the management of peripancreatic collections.

作者: Cecilia Binda.;Chiara Coluccio.;Monica Sbrancia.;Carlo Fabbri.
来源: Minerva Gastroenterol (Torino). 2022年68卷2期162-176页
Pancreatic fluid collections are surrounded by a wall of granulation tissue and may contain necrotic debris. They occur following a severe acute pancreatitis and most of the cases resolve spontaneously after several weeks. However, their management may lead to a very hard-to-treat condition, requiring a multidisciplinary approach. During the last decades we assisted to a change of paradigm involving Endoscopic Ultrasonography, from a pure diagnostic technique to an interventional-therapeutic one, allowing an effective, safe and less invasive approach than other existing treatment standards, historically consisting of surgical and percutaneous drainage. Treatment of pancreatic fluid collections is indicated if they become infected or symptomatic. Over the past years, exponential developments were done in interventional endoscopic approach, making it the first line suggested modality. The use of endoscopic ultrasound allows assessment of the collection, even when it is not directly bulging on gastrointestinal wall, creation of an internal fistulous tract, checking for surrounding vessels with the use of Doppler, and deployment of a stent avoiding the discomfort of external tubes. Several types of stent have been used for endoscopic drainage: plastic double pigtail stents, fully covered self-expanding metal stents and, more recently, lumen apposing metal stents, which are considered revolutionary because of their two-side flanges and wide and short internal channel, a new design that made easier direct endoscopic necrosectomy. This review aims to go through currently available literature on the diagnostic and therapeutic role of endoscopic ultrasonography to handle pancreatic fluid collections.
共有 4689 条符合本次的查询结果, 用时 3.8207129 秒